中国生物制药(SBP GROUP)迈出重要一步,与Tempo Scan达成合作,共同组建一家合资企业。这家新公司名为PT Tempo Cttq Biopharmaceutical Indonesia,标志着双方在印尼市场的战略布局正式落地。通过这一合作,中国生物制药旨在拓展其国际业务版图,并借助Tempo Scan的本地经验,进一步深耕东南亚医药领域。
中国生物制药(SBP GROUP)迈出重要一步,与Tempo Scan达成合作,共同组建一家合资企业。这家新公司名为PT Tempo Cttq Biopharmaceutical Indonesia,标志着双方在印尼市场的战略布局正式落地。通过这一合作,中国生物制药旨在拓展其国际业务版图,并借助Tempo Scan的本地经验,进一步深耕东南亚医药领域。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.